Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line

por He, Zhiyong, Gong, Fusheng, Liao, Jinrong, Wang, Qiang, Su, Ying, Chen, Chao, Lin, Jinghui, Lin, Ren-Jang
Publicado 2020